Tag: platform

London, UK, July 01, 2025 (GLOBE NEWSWIRE) -- As Bitcoin (BTC) breaks through its all-time high in the first half of 2025, the global cryptocurrency market has ushered in a new wave of growth. Riding on the continuous inflow of spot ETF funds and the hot topic of green mining, FINDMINING (https://findmining.com) officially launched its revolutionary free cloud mining platform, dedicated to helping global investors maximize the passive income of mainstream cryptocurrencies such as Bitcoin (BTC) and Litecoin (LTC).

SHREWSBURY, United Kingdom, July 01, 2025 (GLOBE NEWSWIRE) -- Lightchain AI, the AI-native blockchain infrastructure platform, has entered its Bonus Round after successfully completing 15 presale stages and raising more than $21.1 million from early supporters. The Bonus Round is now live at a fixed token price of $0.007125, marking the final opportunity for contributors to access Lightchain AI tokens before the mainnet launch scheduled for July 2025.

New York, NY, July 01, 2025 (GLOBE NEWSWIRE) -- A Trusted Gateway to Risk-Free Crypto Earnings

Expert Consumers names Kikoff the top credit-building app of 2025 for its accessible pricing, no-interest plans, and consistent credit reporting for first-time users.

London, UK, July 01, 2025 (GLOBE NEWSWIRE) -- With Bloomberg analysts raising the probability of approval for a Ripple (XRP) spot exchange-traded fund (ETF) to an impressive 95%, global crypto market sentiment is surging as institutional investors face an unprecedented opportunity to enter the market. As the world’s leading cryptocurrency cloud mining platform, FINDMINING has announced plans to expand its services and computing resources to help global users capture the opportunities brought by this ETF boom.

SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company applying its proprietary Cloudbreak^® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that the Compensation and Human Capital Committee of its Board of Directors (Compensation Committee) granted non-qualified stock option awards and restricted stock units (RSUs) for an aggregate of 12,100 shares of its common stock to two new employees, pursuant to the Cidara Therapeutics, Inc. 2020 Inducement Incentive Plan, as amended (the Inducement Plan), with a grant date of June 30, 2025. The stock option has an exercise price of $48.71 per share, which is equal to the closing price of Cidara’s common stock on the grant date. The shares subject to the option will vest over four years, with 25% of the shares vesting on the one-year anniversary of the vesting commencement date and the balance of the shares vesting in a series of 36 successive equal monthly installments thereafter. All RSUs vest in four equal annual installments, with 1/4 vesting on each of the first, second, third and fourth anniversaries of the Quarterly Vesting Date (as defined below) that occurs during the calendar quarter that includes the date of grant. “Quarterly Vesting Date” means March 10, June 10, September 10 or December 10. The awards are subject to the award holder’s continuous service through each vesting date and to the terms and conditions of the Inducement Plan and the standard forms of grant agreements thereunder.